Safety and Efficacy of Empagliflozin in Hemodialysis
NCT05786443
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
End Stage Renal Disease
Interventions
DRUG:
Empagliflozin 10 MG
DRUG:
Placebo
Sponsor
NYU Langone Health
Collaborators
[object Object]
[object Object]